Markets
Positive
BlossomHill Therapeutics Announces Upcoming Poster Presentation on Phase 1/2 SOLARA Trial of BH-30643, a First-in-class, Macrocyclic OMNI-EGFR™ Inhibitor, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Breaking news from global financial markets
il y a 3 semaines
Lire Plus
il y a 3 semaines
1,483
CST-GA Extends Agreement with TransUnion for Call Authentication Support for Canadian Carriers
Markets
il y a 3 semaines
4,646
Soleo Health Introduces State-of-the-Art Pharmacy and Infusion Center in Washington, D.C., Area
Markets
il y a 3 semaines
1,408
il y a 3 semaines
3,356
il y a 3 semaines
2,265
il y a 3 semaines
3,591
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
Markets
il y a 3 semaines
3,074
il y a 3 semaines
759
il y a 3 semaines
3,927
il y a 3 semaines
2,639
il y a 3 semaines
4,689
il y a 3 semaines
1,087
il y a 3 semaines
607
il y a 3 semaines
1,445
il y a 3 semaines
1,960
il y a 3 semaines
4,912
il y a 3 semaines
4,799
il y a 3 semaines
4,668
Tendances Actuelles
1
IO DeFi Launches New Mobile App, Making BTC and XRP Hashrate Earnings Accessible...
39,538
il y a 2 jours
2
BPCE : Mise à disposition du troisième amendement au document d’enregistrement u...
31,481
il y a 2 jours
3
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit w...
25,488
il y a 2 jours
4
BTCC November 2025 Product Update: Exchange Introduces Futures Pro Copy Trading
16,537
il y a 2 jours
5
Trex Company, Inc. (TREX) Faces Investor Scrutiny Amid Disappointing Q3, Revised...
18,274
il y a 2 jours